tirzepatide 11.25 mg Pills How to calculate the units

The documented research protocol starts at 2 mg once weekly and escalates stepwise roughly every four weeks toward maintenance targets such as 4, 8, and 12 mg

This gradual titration allows your body to adapt to GLP-1 and GIP signaling, reducing nausea and optimizing visceral fat mobilization

Body composition changes may not be accurately reflected by scale weight alone

Tirzepatide, sold under the brand names Mounjaro and Zepbound, is a once-weekly subcutaneous injectable medication primarily used to treat type 2 diabetes and chronic weight management in combination with a low-calorie diet and exercise

ClinicalTrials.gov Rosenstock J, Frias JP, Jastreboff AM, et al